维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="Uronis"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Modulation of the intestinal microbiota alters colitis-associated colorectal cancer sus-ceptibility 显示文摘	Uronis JM Muhlbauer M Herfarth HH	2009	PLoS One2009，4，6：	1
2	VSL#3 probi-otic modifies mucosal microbial composition but does not re-duce colitis-associated colorectal cancer 显示文摘	Arthur J C Gharaibeh R Z Uronis J M	2013	Scientific Re-ports2013，3，：	1
3	Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility显示文摘	Uronis JM Mühlbauer M Herfarth HH	2009	PLo S One2009，4，6：	1
4	A phase II study of capecitabine, oxaliplatin , and Bevacizumab in the treat?ment of metastatic esophageal - gastric adenocarcinomas显示文摘	Uronis HE Bendell JC Altomare I	2013	Oncologist2013，18，3：	1
5	A phase Ⅱ study of capecitabine,oxaliplatin,and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas显示文摘	Uronis HE Bendell JC Altomare Ⅰ	2013	Oncologist2013，18，3：	1
6	A phase II study of capecitabine,oxaliplatin,and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas显示文摘	Uronis HE Bendell JC Altomare I	2013	Oncologist2013，18，：	1
7	Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility显示文摘	Uronis JM Muhlbauer M Herfarth HH	2009	PLoS One2009，4，6：	1
8	NLRP12 Suppresses Colon Inflammation and Tumorigenesis through the Negative Regulation of Noncanonical NF-κB Signaling显示文摘	Irving C. Allen Justin E. Wilson Monika Schneider John D. Lich Reid A. Roberts Janelle C. Arthur Rita-Marie T. Woodford Beckley K. Davis Joshua M. Uronis Hans H. Herfarth Christian Jobin Arlin B. Rogers Jenny P.-Y. Ting	2012	Immunity2012，，5：	1
9	A phase I study of bevacizumab,everolimus and panitumumab in advanced solid tumors显示文摘	Vlahovic G Meadows K L Uronis H E	2012	Cancer Chem Pharmacol2012，70，1：	1
10	Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility显示文摘	Uronis JM Mühlbauer M Herfarth HH	2009	PLo S One2009，4，6：	1
11	A phase Ⅰ study of gemcitabine plus dasatinib (GD) or gemcitabine plus dasatinib plus cetuximab (GDC) in refractory solid tumors显示文摘	Uronis HE Bullock K Blobe G	2009	J Clin Oncol2009，27，15：	1
12	Histological and molecular evaluation of patient-derived colorectal cancer explants显示文摘	Uronis JM Osada T Mccall S	2012	PLoS One2012，7，38：	1
13	Anal cancer:an overview显示文摘	Uronis HE Bendell JC		0，，：	1
14	Assessment of the psychometric properties of an English version of the cancer dyspnea scale in people with advanced lung cancer显示文摘	Uronis H E Shelby R A Currow D C	2012	Journal of pain and symptom management2012，44，5：	1
15	Modulation of the intestinal microbiota alters colitis- associated colorectal cancer susceptibility显示文摘	Uronis J M Muhlbauer M Herfarth H H	2009	PLoS One2009，4，6：	1
16	Mu opioid signaling protects against acute murine intestinal irdury in a manner involving 8tat 3 signaling显示文摘	Goldsmith JE Uronis JM Jobin C	2011	The American Journal of Pathology2011，179，2：	1
17	Randomized phase Ⅱ study of the efficacy and safety of gemcitabine plus TH-302 versus gemcitabine alone in previously untreated patients with advanced pancreatic cancer 显示文摘	BORAD MJ SIGAL D URONIS H	2011	J Clin Oncol2011，，：	1
18	Modulation of the intestinal microbiota alters colitis-associated colorectal cancer sus- ceptibility显示文摘	Uronis JM M hlbauer M Herfarth HH	2009	PLoS One2009，4，6：	1
19	Management of dyspnea in patients with chronic obstructive pulmonary disease显示文摘	Abernethy AP Uronis HE Wheeler JL	2009	Wien Med Wochenschr2009，159，2324：	1
20	Review of dimensioning and toleraneing: representation and processing显示文摘	Urony C Liu R Woo T C	1991	Computer Aided Design1991，23，7：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示